Abstract
The inflammasome-nucleating cytoplasmic sensor protein NLRP3 (NACHT-, LRR, and PYD domains-containing protein 3, also known as NOD-like receptor pyrin domain-containing 3, NALP3, or cryopyrin) is triggered by a broad spectrum of sterile endogenous danger signals and environmental irritants. Upon activation, NLRP3 engages the adapter protein ASC that in turn recruits the third inflammasome component, the protease caspase-1. Subsequent caspase-1 activation leads to its auto-processing and maturation of the leaderless IL-1 family cytokines IL-1β and IL-18 as well as cleavage of the pore-forming protein Gasdermin D (GSDMD). GSDMD plasma membrane pores, formed by its N-terminus, facilitate IL-1 release and, typically, subsequent cell lysis (pyroptosis). This protocol explains standard methods, which are routinely used in our laboratory to study NLRP3 inflammasome biology in vitro. It includes experimental approaches using primary murine bone marrow-derived macrophages (BMDMs) and bone marrow-derived dendritic cells (BMDCs), human peripheral blood mononuclear cells (PBMCs), as well as inflammasome-competent cell lines (HoxB8 and THP-1 cells). The protocol covers the use of a broad spectrum of established NLRP3 activators and outlines the use of common inhibitors blocking NLRP3 itself or its upstream triggering events. We also provide guidelines for experimental set-up and crucial experimental controls to investigate NLRP3 inflammasome signaling or study new activators and inhibitors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Guo H, Callaway JB, Ting JP-Y (2015) Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21:677–687. https://doi.org/10.1038/nm.3893
Gross O (2012) Measuring the inflammasome. Methods Mol Biol 844:199–222. https://doi.org/10.1007/978-1-61779-527-5_15
Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426. https://doi.org/10.1016/s1097-2765(02)00599-3
Bürckstümmer T, Baumann C, Blüml S et al (2009) An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10:266–272. https://doi.org/10.1038/ni.1702
Fernandes-Alnemri T, Yu J-W, Datta P et al (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509–513. https://doi.org/10.1038/nature07710
Hornung V, Ablasser A, Charrel-Dennis M et al (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514–518. https://doi.org/10.1038/nature07725
Roberts TL, Idris A, Dunn JA et al (2009) HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323:1057–1060. https://doi.org/10.1126/science.1169841
Poeck H, Bscheider M, Gross O et al (2010) Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 11:63–69. https://doi.org/10.1038/ni.1824
Xu H, Yang J, Gao W et al (2014) Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513:237–241. https://doi.org/10.1038/nature13449
Miao EA, Alpuche-Aranda CM, Dors M et al (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7:569–575. https://doi.org/10.1038/ni1344
Franchi L, Amer A, Body-Malapel M et al (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7:576–582. https://doi.org/10.1038/ni1346
Miao EA, Mao DP, Yudkovsky N et al (2010) Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA 107:3076–3080. https://doi.org/10.1073/pnas.0913087107
Boyden ED, Dietrich WF (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 38:240–244. https://doi.org/10.1038/ng1724
Xu H, Shi J, Gao H et al (2019) The N-end rule ubiquitin ligase UBR2 mediates NLRP1B inflammasome activation by anthrax lethal toxin. EMBO J 38:e101996. https://doi.org/10.15252/embj.2019101996
Sandstrom A, Mitchell PS, Goers L et al (2019) Functional degradation: a mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes. Science. https://doi.org/10.1126/science.aau1330
Chui AJ, Okondo MC, Rao SD et al (2019) N-terminal degradation activates the NLRP1B inflammasome. Science 364:82–85. https://doi.org/10.1126/science.aau1208
Bauernfried S, Scherr MJ, Pichlmair A et al (2021) Human NLRP1 is a sensor for double-stranded RNA. Science. https://doi.org/10.1126/science.abd0811
Huang M, Zhang X, Toh GA et al (2021) Structural and biochemical mechanisms of NLRP1 inhibition by DPP9. Nature 592:773–777. https://doi.org/10.1038/s41586-021-03320-w
Swanson KV, Deng M, Ting JP-Y (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19:477–489. https://doi.org/10.1038/s41577-019-0165-0
Muñoz-Planillo R, Kuffa P, Martínez-Colón G et al (2013) K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38:1142–1153. https://doi.org/10.1016/j.immuni.2013.05.016
Rathinam VAK, Vanaja SK, Waggoner L et al (2012) TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150:606–619. https://doi.org/10.1016/j.cell.2012.07.007
Hayward JA, Mathur A, Ngo C, Man SM (2018) Cytosolic recognition of microbes and pathogens: inflammasomes in action. Microbiol Mol Biol Rev. https://doi.org/10.1128/MMBR.00015-18
Bauernfeind FG, Horvath G, Stutz A et al (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787–791. https://doi.org/10.4049/jimmunol.0901363
He Y, Zeng MY, Yang D et al (2016) NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530:354–357. https://doi.org/10.1038/nature16959
Sharif H, Wang L, Wang WL et al (2019) Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature 570:338–343. https://doi.org/10.1038/s41586-019-1295-z
Hu Z, Zhou Q, Zhang C et al (2015) Structural and biochemical basis for induced self-propagation of NLRC4. Science 350:399–404. https://doi.org/10.1126/science.aac5489
Zhang L, Chen S, Ruan J et al (2015) Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization. Science 350:404–409. https://doi.org/10.1126/science.aac5789
Broz P (2015) Inflammasome assembly: the wheels are turning. Cell Res 25:1277–1278. https://doi.org/10.1038/cr.2015.137
Andreeva L, David L, Rawson S et al (2021) NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation. Cell 184:6299–6312.e22. https://doi.org/10.1016/j.cell.2021.11.011
He W-T, Wan H, Hu L et al (2015) Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res 25:1285–1298. https://doi.org/10.1038/cr.2015.139
Kayagaki N, Stowe IB, Lee BL et al (2015) Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526:666–671. https://doi.org/10.1038/nature15541
Shi J, Zhao Y, Wang K et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526:660–665. https://doi.org/10.1038/nature15514
Kayagaki N, Kornfeld OS, Lee BL et al (2021) NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591:131–136. https://doi.org/10.1038/s41586-021-03218-7
Gross O, Poeck H, Bscheider M et al (2009) Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459:433–436. https://doi.org/10.1038/nature07965
Groß CJ, Mishra R, Schneider KS et al (2016) K(+) Efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45:761–773. https://doi.org/10.1016/j.immuni.2016.08.010
Franchi L, Eigenbrod T, Muñoz-Planillo R et al (2014) Cytosolic double-stranded RNA activates the NLRP3 inflammasome via MAVS-induced membrane permeabilization and K+ efflux. J Immunol 193:4214–4222. https://doi.org/10.4049/jimmunol.1400582
Pétrilli V, Papin S, Dostert C et al (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14:1583–1589. https://doi.org/10.1038/sj.cdd.4402195
Perregaux D, Gabel CA (1994) Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 269:15195–15203
Neuwirt E, Gorka O, Saller BS et al (2021) NLRP3 as a sensor of metabolism gone awry. Curr Opin Biotechnol 68:300–309. https://doi.org/10.1016/j.copbio.2021.03.009
Hornung V, Bauernfeind F, Halle A et al (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9:847–856
Chen J, Chen ZJ (2018) PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature 564:71–76. https://doi.org/10.1038/s41586-018-0761-3
Coll RC, Robertson AAB, Chae JJ et al (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21:248–255. https://doi.org/10.1038/nm.3806
Shao B-Z, Xu Z-Q, Han B-Z et al (2015) NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol 6:262. https://doi.org/10.3389/fphar.2015.00262
Duncan JA, Bergstralh DT, Wang Y et al (2007) Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci USA 104:8041–8046. https://doi.org/10.1073/pnas.0611496104
Tapia-Abellán A, Angosto-Bazarra D, Martínez-Banaclocha H et al (2019) MCC950 closes the active conformation of NLRP3 to an inactive state. Nat Chem Biol 15:560–564. https://doi.org/10.1038/s41589-019-0278-6
Gross O, Yazdi AS, Thomas CJ et al (2012) Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 36:388–400. https://doi.org/10.1016/j.immuni.2012.01.018
Redecke V, Wu R, Zhou J et al (2013) Hematopoietic progenitor cell lines with myeloid and lymphoid potential. Nat Methods 10:795–803. https://doi.org/10.1038/nmeth.2510
Schneider KS, Thomas CJ, Gross O (2013) Inflammasome activation and inhibition in primary murine bone marrow-derived cells, and assays for IL-1α, IL-1β, and caspase-1. Methods Mol Biol 1040:117–135. https://doi.org/10.1007/978-1-62703-523-1_10
Tweedell RE, Malireddi RKS, Kanneganti T-D (2020) A comprehensive guide to studying inflammasome activation and cell death. Nat Protoc 15:3284–3333. https://doi.org/10.1038/s41596-020-0374-9
Demarco B, Grayczyk JP, Bjanes E et al (2020) Caspase-8-dependent gasdermin D cleavage promotes antimicrobial defense but confers susceptibility to TNF-induced lethality. Sci Adv 6:eabc3465. https://doi.org/10.1126/sciadv.abc3465
Bailey JD, Shaw A, McNeill E et al (2020) Isolation and culture of murine bone marrow-derived macrophages for nitric oxide and redox biology. Nitric Oxide 100-101:17–29. https://doi.org/10.1016/j.niox.2020.04.005
Murray PJ, Allen JE, Biswas SK et al (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14–20. https://doi.org/10.1016/j.immuni.2014.06.008
Shio MT, Tiemi Shio M, Eisenbarth SC et al (2009) Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 5:e1000559. https://doi.org/10.1371/journal.ppat.1000559
Lima-Junior DS, Costa DL, Carregaro V et al (2013) Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania. Nat Med 19:909–915. https://doi.org/10.1038/nm.3221
Coll RC, Hill JR, Day CJ et al (2019) MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol 15:556–559. https://doi.org/10.1038/s41589-019-0277-7
van de Veerdonk FL, Joosten LAB, Devesa I et al (2009) Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans. J Infect Dis 199:1087–1096. https://doi.org/10.1086/597274
Lamkanfi M, Malireddi RKS, Kanneganti T-D (2009) Fungal zymosan and mannan activate the cryopyrin inflammasome. J Biol Chem 284:20574–20581. https://doi.org/10.1074/jbc.M109.023689
Martinon F, Pétrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241. https://doi.org/10.1038/nature04516
Briard B, Fontaine T, Samir P et al (2020) Galactosaminogalactan activates the inflammasome to provide host protection. Nature 588:688–692. https://doi.org/10.1038/s41586-020-2996-z
McNeela EA, Burke A, Neill DR et al (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6:e1001191. https://doi.org/10.1371/journal.ppat.1001191
Hoegen T, Tremel N, Klein M et al (2011) The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol 187:5440–5451. https://doi.org/10.4049/jimmunol.1100790
Tzeng T-C, Schattgen S, Monks B et al (2016) A fluorescent reporter mouse for inflammasome assembly demonstrates an important role for cell-bound and free ASC specks during in vivo infection. Cell Rep 16:571–582. https://doi.org/10.1016/j.celrep.2016.06.011
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Saller, B.S., Neuwirt, E., Groß, O. (2023). Methods to Activate the NLRP3 Inflammasome. In: Pelegrín, P., Di Virgilio, F. (eds) NLR Proteins. Methods in Molecular Biology, vol 2696. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3350-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3350-2_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3349-6
Online ISBN: 978-1-0716-3350-2
eBook Packages: Springer Protocols